ArticleJAMA2014
Clinical application of whole-genome sequencing: proceed with care.
Article in JAMA, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
26 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Impact of SLCO1B1 Pharmacogenetic Testing on Patient and Healthcare Outcomes: A Systematic Review.Clinical pharmacology and therapeutics · 2019Pooled it
- Evaluating Approaches for Communication About Genomic Influences on Body Weight.Annals of behavioral medicine : a publication of the Society of Behavioral Medicine · 2015Trial
- Reflexive standardization and the resolution of uncertainty in the genomics clinic.Social studies of science · 2023Article
- Rapid Identification of Drug-Resistant Tuberculosis Genes Using Direct PCR Amplification and Oxford Nanopore Technology Sequencing.The Canadian journal of infectious diseases & medical microbiology = Journal canadien des maladies infectieuses et de la microbiologie medicale · 2022Article
- Practicing precision medicine with intelligently integrative clinical and multi-omics data analysis.Human genomics · 2020Article
- More than Moore's Mores: Computers, Genomics, and the Embrace of Innovation.Journal of the history of biology · 2018Article
- Comprehensive Cancer-Predisposition Gene Testing in an Adult Multiple Primary Tumor Series Shows a Broad Range of Deleterious Variants and Atypical Tumor Phenotypes.American journal of human genetics · 2018Article
- New technologies to uncover the molecular basis of disorders of sex development.Molecular and cellular endocrinology · 2018Review
- Validation of CZECANCA (CZEch CAncer paNel for Clinical Application) for targeted NGS-based analysis of hereditary cancer syndromes.PloS one · 2018Article
- Finding the right balance between precision medicine and personalized care.CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne · 2017Review
- Longevity-Associated FOXO3 Genotype and its Impact on Coronary Artery Disease Mortality in Japanese, Whites, and Blacks: A Prospective Study of Three American Populations.The journals of gerontology. Series A, Biological sciences and medical sciences · 2017Observational
- Sharpening Precision Medicine by a Thorough Interrogation of Metabolic Individuality.Computational and structural biotechnology journal · 2016Review
- Next-Generation Testing for Cancer Risk: Perceptions, Experiences, and Needs Among Early Adopters in Community Healthcare Settings.Genetic testing and molecular biomarkers · 2015Article
- Challenges of using next generation sequencing in newborn screening.Genetics research · 2015Article
- Genetic research on biospecimens poses minimal risk.Trends in genetics : TIG · 2015Review
- Whole genome sequencing in pharmacogenomics.Frontiers in pharmacology · 2015Article
- The Human Genome Project, and recent advances in personalized genomics.Risk management and healthcare policy · 2015Review
- Is the ``$1000 Genome'' really $1000? Understanding the full benefits and costs of genomic sequencing.Technology and health care : official journal of the European Society for Engineering and Medicine · 2015Article
- Genetic Addiction Risk Score (GARS): molecular neurogenetic evidence for predisposition to Reward Deficiency Syndrome (RDS).Molecular neurobiology · 2014Article
- Utility before business.Genetics in medicine : official journal of the American College of Medical Genetics · 2014Article
Corrections and comments
- Comment on
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
PubMed holds no abstract for this paper.
Indexed as
Identifiers
24618961What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.